A Simulation Shows That Early Treatment Of Chronic Hepatitis B Infection Can Cut Deaths And Be Cost-Effective
Open Access
- 1 February 2011
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 30 (2), 340-348
- https://doi.org/10.1377/hlthaff.2008.0905
Abstract
Chronic hepatitis B affects between 800,000 and two million people in the United States and causes 4,000 deaths each year. Yet the costs and benefits of treatment have not been fully evaluated. Using a model that simulates disease progression, we compare treatment programs for hepatitis B that start at an early stage of the disease to treatment that begins at a late stage. Our analysis concludes that early hepatitis B care can improve health, reduce premature deaths, and prevent expensive complications, making it highly cost-effective in the long term. Our results demonstrate the importance of screening for hepatitis B among at-risk groups and then linking screening to treatment. They also illustrate how predictive models can be used to evaluate strategies for improving access to care.Keywords
This publication has 40 references indexed in Scilit:
- Chronic hepatitis B: Update 2009Hepatology, 2009
- Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005AIDS Research and Therapy, 2007
- Underestimation of chronic hepatitis B virus infection in the United States of AmericaJournal of Viral Hepatitis, 2007
- A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An UpdateClinical Gastroenterology and Hepatology, 2006
- Chronic hepatitis B: current epidemiology in the Americas and implications for managementJournal of Viral Hepatitis, 2006
- Treatment and prognostic factors in patients with hepatocellular carcinomaLiver International, 2006
- Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in ratsJournal of Hepatology, 2006
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Changing disease burden of hepatocellular carcinoma in the Far East and Southeast AsiaLiver International, 2005
- Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2005